शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
GRANULESBSEGRANULES INDIA LIMITED· Pharmaceuticals & BiotechnologyHighPositive
Announced Tue, 15 Sept, 2026 · 19:42 IST

Promoter group pays Rs 1,093 cr balance for warrant conversion

Warrants convertedFund Raising View source PDFExplain this filing

GRANULES · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-2.1%Reaction day
₹873.20
prior close
₹869.00
announcement price
After-mkt
timing
Nifty Smallcap 250market-0.2%-1.9% vs market
Pharmaceuticals peers, median of 173sector-0.3%-1.8% vs sector

On the reaction day the stock moved 1.9 pts less than Nifty Smallcap 250 and 1.8 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.3
10m
-0.2
15m
-1.0
30m
-2.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-2.1-0.2-1.9-0.3-1.8
Next day
-0.2+0.7-0.9+0.6-0.8
2d
+0.2+2.2-2.0+1.5-1.3
3d
-0.1+2.2-2.3+1.6-1.7
4d
-1.3+2.1-3.3+1.9-3.1
5d
-1.2+2.9-4.1+2.5-3.7
1w
-0.0+1.5-1.5+0.9-1.0
15d
-7.0-2.3-4.7-3.0-4.0
1m
-5.7-1.4-4.3-3.8-2.0
2m
—————
3m
—————
UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Promoter group paid the balance 75 percent subscription amount of Rs. 1,093 crores towards a preferential allotment on private placement basis. Following this, 2,49,14,530 warrants held by promoter group members are fully paid and now eligible for conversion into equity shares. Granules India will move into a net cash surplus position on a consolidated basis, giving it flexibility to fund growth plans ahead of original timelines.

Likely market impact

Warrants will convert into equity, adding shares but company gains net cash surplus for growth. Minor dilution likely.